Ask AI
ProCE Banner Activity

Clinical Scenarios Podcast: A Deep Dive Into Refractory CMV Infections

Podcast Episodes

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory cytomegalovirus (CMV) infections to minimize antiviral toxicities and maximize efficacy.

Released: September 03, 2025

Share

Provided by

Provided by Clinical Care Options (CCO) in partnership with ProCE

ProCE Banner

Supporters

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Partners

ProCE, LLC

ProCE Banner

Faculty Disclosure

Primary Author

Atul Humar, MD, FRCP (C): consultant/advisor/speaker: Eurofins, Merck, Takeda; researcher: Qiagen.

Camille Kotton, MD, FIDSA, FAST: consultant/advisor/speaker: Abbott, Merck, Qiagen, Roche, Takeda; researcher: Kamada, Takeda.